Comparative molecular profiling of HPV‐induced squamous cell carcinomas von Koncar, Robert F., Feldman, Rebecca, Bahassi, El Mustapha, Hashemi Sadraei, Nooshin

Volltext

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study von Paz-Ares, Luis, Champiat, Stephane, Lai, W Victoria, Izumi, Hiroki, Govindan, Ramaswamy, Boyer, Michael, Hummel, Horst-Dieter, Borghaei, Hossein, Johnson, Melissa L, Steeghs, Neeltje, Blackhall, Fiona, Dowlati, Afshin, Reguart, Noemi, Yoshida, Tatsuya, He, Kai, Gadgeel, Shirish M, Felip, Enriqueta, Zhang, Yiran, Pati, Amrita, Minocha, Mukul, Mukherjee, Sujoy, Goldrick, Amanda, Nagorsen, Dirk, Hashemi Sadraei, Nooshin, Owonikoko, Taofeek K

Volltext

Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Smal... von Zhou, Di, Byers, Lauren A., Sable, Beate, Smit, Marie‐Anne Damiette, Sadraei, Nooshin Hashemi, Dutta, Sandeep, Upreti, Vijay V.

Volltext

Aberrant Signaling Pathways in Squamous Cell Lung Carcinoma von Shi, Ivy, Sadraei, Nooshin Hashemi, Duan, Zhong-Hui, Shi, Ting

Volltext

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer von Chou, Jonathan, Egusa, Emily A, Wang, Sinan, Badura, Michelle L, Lee, Fei, Bidkar, Anil P, Zhu, Jun, Shenoy, Tanushree, Trepka, Kai, Robinson, Troy M, Steri, Veronica, Huang, Jiaoti, Wang, Yuzhuo, Small, Eric J, Chan, Emily, Stohr, Bradley A, Ashworth, Alan, Delafontaine, Brant, Rottey, Sylvie, Cooke, Keegan S, Hashemi Sadraei, Nooshin, Yu, Brian, Salvati, Mark, Bailis, Julie M, Feng, Felix Y, Flavell, Robert R, Aggarwal, Rahul

Volltext

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer von Gulati, Shuchi, Desai, Janki, Palackdharry, Sarah M., Morris, John C., Zhu, Zheng, Jandarov, Roman, Riaz, Muhammad K., Takiar, Vinita, Mierzwa, Michelle, Gutkind, J. Silvio, Molinolo, Alfredo, Desai, Pankaj B., Sadraei, Nooshin Hashemi, Wise‐Draper, Trisha M.

Volltext

An Open‐Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non‐Small Cell Lung Cancer von Patil, Pradnya Dinkar, Shapiro, Marc, Hashemi Sadraei, Nooshin, Pennell, Nathan A.

Volltext

Review: Chemotherapy in newly diagnosed primary central nervous system lymphoma von Hashemi-Sadraei, Nooshin, Peereboom, David M.

Volltext

Spatial characterization and quantification of CD40 expression across cancer types von Bates, Katherine M, Vathiotis, Ioannis, MacNeil, Tyler, Ahmed, Fahad Shabbir, Aung, Thazin Nwe, Katlinskaya, Yuliya, Bhattacharya, Sabyasachi, Psyrri, Amanda, Yea, Steven, Parkes, Amanda, Sadraei, Nooshin Hashemi, Roychoudhury, Siddhartha, Rimm, David L, Gavrielatou, Niki

Volltext

High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer von Hashemi Sadraei, Nooshin, Feng, Yan, Du, Lingling, Fu, Pingfu, Haque, Sulsal, Dowlati, Afshin, Gollamudi, Jahnavi, Pennell, Nathan A., Mekhail, Tarek, Avril, Stefanie, Farver, Carol, Gerson, Stanton L., Sharma, Neelesh

Volltext

Try to Avoid Tri-Modality Treatment von Sadraei, Nooshin Hashemi, MD, Huth, Bradley J., MD

Volltext

The Role of Consolidation Treatment in Locally Advanced Unresectable NSCLC von Fakhrejahani, Farhad, Hashemi Sadraei, Nooshin, Mekhail, Tarek

Volltext

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer von Frankart, Andrew J., Sadraei, Nooshin Hashemi, Huth, Brad, Redmond, Kevin P., Barrett, William L., Kurtzweil, Nicky, Riaz, Muhammad K., Wise‐Draper, Trisha, Rodriguez, Cristina P., Adelstein, David J., Takiar, Vinita

Volltext

Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer von Sadraei, Nooshin Hashemi, Sikora, Andrew G, Brizel, David M

Volltext

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma von Wise-Draper, Trisha, Sendilnathan, Arun, Palackdharry, Sarah, Pease, Nicholas, Qualtieri, Julianne, Butler, Randall, Sadraei, Nooshin Hashemi, Morris, John C., Patil, Yash, Wilson, Keith, Mark, Jonathan, Casper, Keith, Takiar, Vinita, Lane, Adam, Privette Vinnedge, Lisa

Volltext

Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): a multi-center retrospective analysis von Karivedu, Vidhya, Agarwal, Rishi, Haque, Sulsal Ul, Thapa, Bicky, Fakhrejahani, Farhad, Fu, Pingfu, Videtic, Gregory M. M., Sadraei, Nooshin Hashemi

Volltext

359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results von Borghaei, Hossein, Boyer, Michael, Johnson, Melissa, Govindan, Ramaswamy, Rodrigues, Luis Paz-Ares, Blackhall, Fiona, Boosman, Rene, Champiat, Stéphane, Hummel, Horst-Dieter, Victoria Lai, W, Udagawa, Hibiki, Chiang, Anne, Dowlati, Afshin, Hann, Christine, Salgia, Ravi, Vokes, Everett, Minocha, Mukul, Hashemi-Sadraei, Nooshin, Shetty, Aditya, Smit, Marie-Anne Damiette, Yang, Hui, Owonikoko, Taofeek

Volltext

Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer von Hashemi-Sadraei, Nooshin, Sikora, Andrew G, Brizel, David M

Volltext

Abstract CT205: Design and rationale of a phase 1 study evaluating AMG 256, a novel, targeted, PD-1 antibody x IL-21 mutein bifunctional fusion protein, in patients with advanced s... von Durm, Greg, Frentzas, Sophia, Rasmussen, Erik, Najmi, Saltanat, Sadraei, Nooshin Hashemi

Volltext

Phase 1b study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTEimmune-oncology therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate... von Aggarwal, Rahul Raj, Aparicio, Ana, Heidenreich, Axel, Sandhu, Shahneen Kaur, Zhang, Yiran, Salvati, Mark, Shetty, Aditya, Hashemi Sadraei, Nooshin

Volltext